Angel Matthew Insider Profile
4 Followers
Angel Matthew, President & CEO, Director at Eterna Therapeutics, holds ― shares in Eterna Therapeutics (Ticker: ERNA), holds 231.48K shares in Tempest Therapeutics (Ticker: TPST). Most recently, Angel Matthew ― shares of Eterna Therapeutics on ― for an estimated value of ―.
Angel Matthew Eterna Therapeutics (ERNA)President & CEO, Director
Eterna Therapeutics (ERNA)
President & CEO, Director
Ranked #81,148 out of 108,198 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-33.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Angel Matthew holds in companies
Most Profitable Insider Trade
The most profitable trade made by Angel Matthew
Angel Matthew's Trading History
Eterna Therapeutics
―
President & CEO, Director
―
―
Tempest Therapeutics
Jun 23, 2026
CEO & President, Director, Ten Percent Owner
Informative Buy
500.00K
$226.85K
List of latest transactions for each holding click on a transaction to see Angel Matthew's performance on stock
You May Also Like
Angel Matthew insider profile FAQ
What is the percentage of profitable transactions made by Angel Matthew?
The percentage of profitable transactions made by Angel Matthew is 0%.
What is the average return per transaction made by Angel Matthew?
The average return per transaction made by Angel Matthew is -33.20%.
What stocks does Angel Matthew hold?
Angel Matthew holds: ERNA, TPST stocks.
What was Angel Matthew’s latest transaction?
Angel Matthew latest transaction was an Uninformative Buy of ―.
What was Angel Matthew's most profitable transaction?
Angel Matthew’s most profitable transaction was an Informative Buy of TPST stock on June 23, 2026. The return on the trade was -22.40%.
What is Angel Matthew's role in Eterna Therapeutics?
Angel Matthew's role in Eterna Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.